2283 related articles for article (PubMed ID: 9486650)
21. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cell-mediated recognition of human trophoblast.
Biassoni R; Bottino C; Millo R; Moretta L; Moretta A
Semin Cancer Biol; 1999 Feb; 9(1):13-8. PubMed ID: 10092546
[TBL] [Abstract][Full Text] [Related]
23. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.
Miller JD; Weber DA; Ibegbu C; Pohl J; Altman JD; Jensen PE
J Immunol; 2003 Aug; 171(3):1369-75. PubMed ID: 12874227
[TBL] [Abstract][Full Text] [Related]
24. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules.
Carretero M; Cantoni C; Bellón T; Bottino C; Biassoni R; Rodríguez A; Pérez-Villar JJ; Moretta L; Moretta A; López-Botet M
Eur J Immunol; 1997 Feb; 27(2):563-7. PubMed ID: 9045931
[TBL] [Abstract][Full Text] [Related]
25. [CD94/NKG2A--a kind of inhibitory receptor belonging to C-type lectin superfamily].
Wang Y; Zhu LP; Zhang W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):653-5. PubMed ID: 12905700
[TBL] [Abstract][Full Text] [Related]
26. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies.
Sivori S; Vitale M; Bottino C; Marcenaro E; Sanseverino L; Parolini S; Moretta L; Moretta A
Eur J Immunol; 1996 Oct; 26(10):2487-92. PubMed ID: 8898964
[TBL] [Abstract][Full Text] [Related]
27. NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.
Borrego F; Kabat J; Sanni TB; Coligan JE
J Immunol; 2002 Dec; 169(11):6102-11. PubMed ID: 12444112
[TBL] [Abstract][Full Text] [Related]
28. The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells.
Nattermann J; Nischalke HD; Hofmeister V; Ahlenstiel G; Zimmermann H; Leifeld L; Weiss EH; Sauerbruch T; Spengler U
Am J Pathol; 2005 Feb; 166(2):443-53. PubMed ID: 15681828
[TBL] [Abstract][Full Text] [Related]
29. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
Michaëlsson J; Teixeira de Matos C; Achour A; Lanier LL; Kärre K; Söderström K
J Exp Med; 2002 Dec; 196(11):1403-14. PubMed ID: 12461076
[TBL] [Abstract][Full Text] [Related]
30. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.
Lee N; Llano M; Carretero M; Ishitani A; Navarro F; López-Botet M; Geraghty DE
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5199-204. PubMed ID: 9560253
[TBL] [Abstract][Full Text] [Related]
31. CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.
Zingoni A; Palmieri G; Morrone S; Carretero M; Lopez-Botel M; Piccoli M; Frati L; Santoni A
Eur J Immunol; 2000 Feb; 30(2):644-51. PubMed ID: 10671222
[TBL] [Abstract][Full Text] [Related]
32. How do NK cells sense the expression of HLA-G class Ib molecules?
López-Botet M; Navarro F; Llano M
Semin Cancer Biol; 1999 Feb; 9(1):19-26. PubMed ID: 10092547
[TBL] [Abstract][Full Text] [Related]
33. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells.
Vance RE; Tanamachi DM; Hanke T; Raulet DH
Eur J Immunol; 1997 Dec; 27(12):3236-41. PubMed ID: 9464811
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
35. Human T cell receptor-mediated recognition of HLA-E.
García P; Llano M; de Heredia AB; Willberg CB; Caparrós E; Aparicio P; Braud VM; López-Botet M
Eur J Immunol; 2002 Apr; 32(4):936-44. PubMed ID: 11920559
[TBL] [Abstract][Full Text] [Related]
36. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells.
Navarro F; Llano M; Bellón T; Colonna M; Geraghty DE; López-Botet M
Eur J Immunol; 1999 Jan; 29(1):277-83. PubMed ID: 9933109
[TBL] [Abstract][Full Text] [Related]
37. Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics.
Kaiser BK; Barahmand-Pour F; Paulsene W; Medley S; Geraghty DE; Strong RK
J Immunol; 2005 Mar; 174(5):2878-84. PubMed ID: 15728498
[TBL] [Abstract][Full Text] [Related]
38. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
[TBL] [Abstract][Full Text] [Related]
39. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
40. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant.
Lin Chua H; Brahmi Z
Cell Immunol; 2002 Sep; 219(1):57-70. PubMed ID: 12473268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
